This review effectively covers the expanding role of CDK4/6 inhibitors in breast cancer. – https://nicolediem.ch/en/apps/store-locator , The observed reduction in HbA1c is clinically significant; however, patient adherence and real-world tolerability remain important considerations for widespread adoption. .